PFE - PFIZER INC

QQQ $ 463.99 $ 1.20 (0.26 %)

DIA $ 389.14 $ 0.79 (0.2 %)

SPY $ 535.08 $ 1.83 (0.34 %)

TLT $ 90.87 $ -0.16 (-0.18 %)

GLD $ 213.70 $ 0.61 (0.29 %)

Previous Close

$ 28.58

Open

$ 28.39

Bid

$ 28.10 x 600

Ask

$ 28.11 x 1,327

Day's Range

$ 27.64 - $ 28.39

52 Week Range

$ 24.83 - $ 38.23

Volume

27,526,200

Average Volume

Market Cap

162.82B

Beta (5Y Monthly)

$ 0.58

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.06)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-08-2023	10-01-2023	10-Q
4	08-09-2023	07-02-2023	10-Q
5	05-10-2023	04-02-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-09-2022	10-02-2022	10-Q
8	08-10-2022	07-03-2022	10-Q
9	05-11-2022	04-03-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-12-2021	10-03-2021	10-Q
12	08-12-2021	07-04-2021	10-Q
13	05-13-2021	04-04-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-05-2020	09-27-2020	10-Q
16	08-06-2020	06-28-2020	10-Q
17	05-07-2020	03-29-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	11-07-2019	09-29-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	02-28-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-09-2018	07-01-2018	10-Q
25	05-10-2018	04-01-2018	10-Q
26	02-22-2018	12-31-2017	10-K
27	11-09-2017	10-01-2017	10-Q
28	08-10-2017	07-02-2017	10-Q
29	05-11-2017	04-02-2017	10-Q
30	02-23-2017	12-31-2016	10-K
31	11-10-2016	10-02-2016	10-Q
32	08-11-2016	07-03-2016	10-Q
33	05-12-2016	04-03-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	11-05-2015	09-27-2015	10-Q
36	08-06-2015	06-28-2015	10-Q
37	05-07-2015	03-29-2015	10-Q
38	02-27-2015	12-31-2014	10-K
39	11-06-2014	09-28-2014	10-Q
40	08-07-2014	06-29-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

spotlight-on-pfizer-analyzing-the-surge-in-options-activity

Spotlight on Pfizer: Analyzing the Surge i...
06/10/2024 17:15:55

moderna-seeks-fda-approval-for-updated-covid-19-shot-for-upcoming-season

Moderna Seeks FDA Approval For Updated COV...
06/07/2024 16:05:42

Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.

FDA Advised Manufacturers Of Authorized Co...
06/07/2024 14:47:41

- Reuters

Check Out What Whales Are Doing With PFE
06/06/2024 17:31:37

Novavax Says FDA Panel Backs Update For Mo...
06/05/2024 20:36:55

- Bloomberg

Relay Therapeutics And Pfizer Collaborate ...
06/05/2024 20:31:34

Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by ...

'First-ever human death of bird flu strain...
06/05/2024 20:22:27

https://globalnews.ca/news/10547712/bird-flu-death-mexico-h5n2/#:~:text=It%20started%20on%20April%2017,to%20complications%20of%...

FDA Advisers Support Inclusion Of JN1 COVI...
06/05/2024 19:23:35

- Bloomberg

FDA Advisers Vote In Favor Of Recommending...
06/05/2024 18:51:23

- Reuters

What's Going On With Novavax Stock?
06/05/2024 17:21:35

Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look...

alphabet-ventas-asml-and-a-pharmaceutical-giant-on-cnbcs-final-trades

Alphabet, Ventas, ASML And A Pharmaceutica...
06/05/2024 13:28:27

Alphabet recently declared a $2 billion investment plan to establish its inaugural data center and Google Cloud region in Malay...

Pfizer And Partner BioNTech Says Prepared ...
06/05/2024 12:15:08

- Reuters

promising-trial-results-show-new-standards-in-cancer-treatment-and-diagnostics-are-on-the-horizon

Promising Trial Results Show New Standards...
06/04/2024 17:45:09

On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a...

CNBC Halftime Report Final Trades: Pfizer,...
06/04/2024 17:01:52

Pfizer Unusual Options Activity For June 03
06/03/2024 18:01:09

Live On CNBC, Pfizer CEO Albert Bourla Dis...
06/03/2024 14:56:08

WATCH: Dr. Fauci Testifies Live On COVID-1...
06/03/2024 14:49:38

https://www.youtube.com/watch?v=qCsEbq9SpsM

U.S. FDA Staff Says Covid Vaccine Makers S...
06/03/2024 14:03:33

- Reuters - Reuters

$saturday-pfizer-announced-detailed-overall-survival-results-from-phase-3-echelon-3-study-of-adcetris-plus-lenalidomide-and-rituximab-for-relapsedrefractory-diffuse-large-b-cell-lymphoma-showing-adcetris-combo-reduced-risk-of-death-by-37-vs-placebo$

Saturday, Pfizer Announced Detailed Overal...
06/03/2024 09:04:09

Saturday, Takeda And Pfizer Announced Pres...
06/03/2024 09:01:31

The four-year analysis showed superior progression-free survival (PFS) and improved tolerability for patients compared to a cur...